PEPTONIC medical AB (publ) (XSAT:PMED)

Market Cap	92.09M +158.1%
Revenue (ttm)	14.79M -45.0%
Net Income	-22.50M
EPS	-0.00
Shares Out	1.53B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	204,022
Average Volume	936,467
Open	0.0600
Previous Close	0.0600
Day's Range	0.0560 - 0.0600
52-Week Range	0.0500 - 0.1550
Beta	-0.00
RSI	50.31
Earnings Date	Apr 30, 2026

About PEPTONIC medical AB

PEPTONIC medical AB (publ), a medical technology company, develops and sells intimate self-care products for women. The company offers products under the VagiVital brand, including a moisturizing gel for atrophy; an intimate calming gel for rapid relief of itching and irritation; moisturizing lubricant; a pH-balancing intimate wash/conditioner; self-test kits for diagnosing pre-menopause, menopause, vaginal infection, bacterial vaginosis, and amniotic fluid leakage; and gene test for diagnosing vaginal infection. It also provides VerniVia mouss...

• Industry: Pharmaceutical Preparations
• Founded: 2009
• Employees: 2
• Stock Exchange: Spotlight Stock Market
• Ticker Symbol: PMED

Financial Performance

In 2025, PEPTONIC medical AB's revenue was 14.79 million, a decrease of -45.01% compared to the previous year's 26.89 million. Losses were -22.50 million, -62.53% less than in 2024.